Al-Terki, H.; Gotzmann, M.; Mahfoud, F.; Lauder, L.; Mügge, A.
Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis. J. Clin. Med. 2023, 12, 4006.
https://doi.org/10.3390/jcm12124006
AMA Style
Al-Terki H, Gotzmann M, Mahfoud F, Lauder L, Mügge A.
Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis. Journal of Clinical Medicine. 2023; 12(12):4006.
https://doi.org/10.3390/jcm12124006
Chicago/Turabian Style
Al-Terki, Hani, Michael Gotzmann, Felix Mahfoud, Lucas Lauder, and Andreas Mügge.
2023. "Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis" Journal of Clinical Medicine 12, no. 12: 4006.
https://doi.org/10.3390/jcm12124006
APA Style
Al-Terki, H., Gotzmann, M., Mahfoud, F., Lauder, L., & Mügge, A.
(2023). Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis. Journal of Clinical Medicine, 12(12), 4006.
https://doi.org/10.3390/jcm12124006